Press

Piramal Pharma Limited Logo

Piramal Pharma Limited Announces Results for Q1FY26

MUMBAI, India, July 28, 2025 /PRNewswire/ — Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceutical, and health and wellness company, today announced its standalone and consolidated results for the First Quarter (Q1) ended 30th June 2025. Consolidated Financial Highlights (in ₹ Crores or as stated) Particulars Q1FY26 Q1FY25 YoY Growth Revenue from […]

Piramal Pharma Limited Announces Results for Q1FY26 Read Post »

Press

Biologic Therapeutics Market to Hit $794.5 Billion by 2029

“Driven by Rising Chronic Disease Burden and Breakthrough FDA Approvals, Biopharmaceutical Market Surges with Demand for Monoclonal Antibodies, Gene and Cell Therapies, and Innovative Vaccines” BOSTON, July 28, 2025 /PRNewswire/ — According to the latest study from BCC Research, “Biologic Therapeutic Drugs: Technologies and Global Markets” is projected to increase from $499.2 billion in 2024 to

Biologic Therapeutics Market to Hit $794.5 Billion by 2029 Read Post »

Press

DATA BREACH ALERT: Edelson Lechtzin LLP is Investigating Claims on Behalf of The Velocity Risk Underwriters, LLC Customers Whose Data May Have Been Compromised

NEWTOWN, Pa., July 28, 2025 /PRNewswire/ — The law firm of Edelson Lechtzin LLP, in suburban Philadelphia, is investigating data privacy claims regarding an incident at Velocity Risk Underwriters, LLC (“Velocity”). Velocity learned of a data breach on or about April 28, 2025. If you would like to discuss your options with a lawyer, please

DATA BREACH ALERT: Edelson Lechtzin LLP is Investigating Claims on Behalf of The Velocity Risk Underwriters, LLC Customers Whose Data May Have Been Compromised Read Post »

Press
image 5009787 56433335 1

CGTN : Comment l’économie chinoise reste dynamique malgré la guerre tarifaire avec les États-Unis

PÉKIN, 28 juillet 2025 /PRNewswire/ — Alors que le vice-Premier ministre chinois He Lifeng s’apprête à mener des négociations économiques et commerciales avec les États-Unis en Suède à la fin du mois, la force et la résilience de l’économie chinoise sont une nouvelle fois sous les feux de la rampe. Cette série de discussions, convenues

CGTN : Comment l’économie chinoise reste dynamique malgré la guerre tarifaire avec les États-Unis Read Post »

Press
Monteverde Associates PC Logo

SHAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate Merger of FL, ENZB, HSON, and BRZH

NEW YORK, July 28, 2025 /PRNewswire/ — Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are

SHAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate Merger of FL, ENZB, HSON, and BRZH Read Post »

Press
Monteverde Associates PC Logo

$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate Merger of TTNP, BASE, SPTN, and CFSB

NEW YORK, July 28, 2025 /PRNewswire/ — Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are

$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate Merger of TTNP, BASE, SPTN, and CFSB Read Post »

Press

Treatment Action Group to Honor Gloria Reuben at 2025 Research in Action Awards

“When HIV was still seen as a death sentence, I worked closely with producers to ensure Jeanie would not die from AIDS.” Post this Gloria Reuben is celebrated for her role as Jeanie Boulet on ER—a character who brought visibility and nuance to HIV at a critical time in the mid‑1990s. “Playing Jeanie Boulet on

Treatment Action Group to Honor Gloria Reuben at 2025 Research in Action Awards Read Post »

Press
Scroll to Top